Current
Tozaro
Life Sciences
•
East of England
•
Early Stage
•
2020
Tozaro (previously MIP Discovery) designs and develops synthetic affinity reagents, with the aim of enhancing complex cell and gene therapy processes.
Looking for funding?
We’ve already helped hundreds of ambitious businesses in the UK and Ireland to accelerate their growth. If you’re looking for a minority investment partner that can provide long-term, flexible funding and support, please get in touch with our team today.
